Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 09. December 2025
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3377  Previews Next
   
   Articles 1 - 20 / 67527  
   
Benzodiazepine use in schizophrenia: A review of the literature.
Ment Health Clin
Noel C, Maclay C.
PMID: 41358044 [PubMed]


Review of clinical medication adherence in patients with schizophrenia.
World J Psychiatry
Zhao F, Zhong H, Kang PP, Sun SM, Zhang TQ, Cui SN, Bi SJ.
PMID: 41357942 [PubMed]


The Ketogenic Diet: An Anti-Inflammatory Treatment for Schizophrenia?
J Inflamm Res
Hung AA, Krycer JR, Sarnyai Z, Palmer CM, Navarro S.
PMID: 41357841 [PubMed]


Psychosis in the Deaf Population: Prevalence, Phenomenology, and Diagnostic Challenges: A Narrative Review.
Cureus
Sarwar H, Hamoudeh K, Ahmadzada M, Dhingra M, Batmaz E, Adnan M, Nichols C, Seikunas J.
PMID: 41357028 [PubMed]


Lumateperone Safety and Tolerability in Schizophrenia: A Narrative Review.
Cureus
Montaser J, Tumu S, Maram Reddy VY, Jayasuriya N, Ali M, Munir A, Elmontaser M.
PMID: 41356959 [PubMed]


Janus kinase/signal transducer and activator of transcription pathway in schizophrenia (Review).
Biomed Rep
Rizos E, Theleritis C, Tsoporis JN, Spandidos DA, Katsantoni E.
PMID: 41356389 [PubMed]


Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatients.
Biomed Rep
Petrovic V, Cohen D, Bankovic D, Radmanovic B, Ignjatovic Ristic D.
PMID: 41356387 [PubMed]


Memantine as an Adjuvant in Cognitive Symptoms of Schizophrenia with a Chronic Course: A Follow-up Study.
Indian J Psychol Med
Salaam MA, Koyilada G, Kiran DR.
PMID: 41356211 [PubMed - as supplied by publisher]


Neuroimaging and Glutamatergic Trials in Psychosis: Where Are We Standing, and Where Do We Go Now?
Biol Psychiatry Cogn Neurosci Neuroimaging
de la Fuente-Sandoval C.
PMID: 41354465 [PubMed - in process]


Differences in Prefrontal Cortex Activation Between Predominantly Positive and Negative Symptom Profiles in Schizophrenia: A Functional Near-Infrared Spectroscopy Study.
Med Sci Monit
Liang Y, Jiang H, Liu B, Liao J, Feng Y, He R, Zhang S, Tan Y.
PMID: 41351254 [PubMed - indexed for MEDLINE]


Fracture risk in the offspring of individuals with schizophrenia: A cohort study of 71,698 children.
Schizophr Res
Wang SC, Hsu JW, Tsai SJ, Bai YM, Su TP, Chen TJ, Huang WS, Chen MH.
PMID: 41349381 [PubMed - as supplied by publisher]


Correction: Treatment discontinuation of remotely delivered cognitive remediation for schizophrenia: a systematic review and meta-analysis.
Front Psychiatry
Wen M, Zhang J, Jiang K, Liu J, Zhu X.
PMID: 41346642 [PubMed]


The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective.
Front Immunol
Su BW, Li Y, Yang LY, Yang HX, Wang WH, Ren HW, Bao YN, Lao JY, Luan ZL.
PMID: 41346597 [PubMed - indexed for MEDLINE]


Pilot of Dialectical Behavior Therapy (DBT) skills training for people with psychosis spectrum conditions and high risk of suicide.
Psychosis
Phalen P, Lucksted A, Fox K, Yusuf A, Hochheiser J, Jones N, Fetisova A, Hackman A, Bennett M.
PMID: 41346404 [PubMed]


The effects of visual remediation intervention in patients with schizophrenia: an exploratory randomized controlled trial.
Int J Psychiatry Clin Pract
Corum EN, Dundar E, Seitz A, Tas C.
PMID: 41346292 [PubMed - as supplied by publisher]


Dimensions of Schizophrenia Spectrum Symptomatology and Time Perception: a Systematic Review.
Schizophr Bull
Konstantin GE, Lenzenweger MF.
PMID: 41345998 [PubMed - as supplied by publisher]


Effectiveness of implementing family involvement on patient outcomes in individuals with psychotic disorders: a pragmatic cluster randomised controlled trial.
BMC Psychiatry
Norheim I, Pedersen R, Selle ML, Røssberg JI, Hestmark L, Heiervang KS, Ruud T, Åsholt VM, Hansson KM, Møller P, Fosse R, Kjus SHH, Romøren M.
PMID: 41345598 [PubMed - indexed for MEDLINE]


Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study.
J Natl Med Assoc
Ahmed S, Beyene E, Bisrat M, Falegan T, Hemphill A, Mack A, Elkomi R, Zinabu S, Michael M.
PMID: 41344981 [PubMed - as supplied by publisher]


The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).
Eur Neuropsychopharmacol
de Boer N, Vu, Koster DI, van der Horst M, Davidson M, Cahn W, Luykx JJ.
PMID: 41344122 [PubMed - as supplied by publisher]


Efficacy of high-frequency transcranial magnetic stimulation to improve negative symptoms in patients with Schizophrenia: A meta-analysis of randomized controlled trials.
Psychiatry Res
Chen H, Li J, Jia X, Wang X, Qiao R, Yao G, Zhong J.
PMID: 41343889 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 67527    Page 1 of 3377  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1